Topic: Corporate Governance

Nasdaq Provides Temporary Exemption from Certain Shareholder Approval Requirements in Response to COVID-19
SEC Releases COVID-19 FAQs to Provide Guidance on Disclosure Requirements and Form S-3
Now Available: COVID-19 Resources for Public Companies
Disclosure Considerations: One Month Into the U.S. Outbreak
ISS Provides Policy Guidance in Light of COVID-19 Pandemic
Key Governance Action Items in Response to COVID-19
Delaware Governor Issues Limited Relief for Public Company Shareholder Meetings Impacted by COVID-19
SEC Extends Conditional Exemptions From Reporting and Proxy Delivery Requirements for Public Companies Affected By COVID-19 For Reports due on or before July 1, 2020 4/1/2020
SEC Amends Accelerated and Large Accelerated Filer Definitions to Reduce Burdens on Smaller Reporting Companies – Effective April 27, 2020
Reconsidering Poison Pills
1 - 10 Next

 Error

Web Part Error: A Web Part or Web Form Control on this Page cannot be displayed or imported. The type could not be found or it is not registered as safe. Correlation ID: c45e6d9f-99bb-c0be-c3d3-9709b5de43de.

© Copyright 2018 Gibson, Dunn & Crutcher LLP.
Attorney Advertising. Prior results do not guarantee a similar outcome. All information provided on this site is for informational purposes only, does not constitute legal advice, is not confidential, and does not create an attorney-client relationship. Statements and content posted to this site do not represent the opinion of Gibson Dunn & Crutcher LLP ("Gibson Dunn"). Gibson Dunn makes no representations as to the accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors or omissions therein, nor for any losses, injuries, or damages arising from its display or use.